Juan José Gómez-Doblas1, Javier Muñiz2, Joaquín J Alonso Martin3, Gustavo Rodríguez-Roca4, José Maria Lobos5, Paula Awamleh3, Gaietá Permanyer-Miralda6, Francisco Javier Chorro7, Manuel Anguita8, Eulalia Roig9. 1. Servicio de Cardiología, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain. Electronic address: jjgomezdoblas@secardiologia.es. 2. Instituto Universitario de Ciencias de la Salud, Universidad de A Coruña, A Coruña, Spain. 3. Servicio de Cardiología, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain. 4. Centro de Salud La Puebla de Montalbán, Toledo, Spain. 5. Centro de Salud Jazmín, Madrid, Spain. 6. Servicio de Cardiología, Hospital Universitario Vall d'Hebron, Barcelona, Spain. 7. Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain. 8. Servicio de Cardiología, Hospital Reina Sofía, Córdoba, Spain. 9. Servicio de Cardiología, Hospital de Sant Pau, Barcelona, Spain.
Abstract
INTRODUCTION AND OBJECTIVES: Atrial fibrillation is associated with substantial morbidity and mortality and both its incidence and prevalence are high. Nevertheless, comprehensive data on this condition in Spain are lacking. The aim of this study was to estimate the prevalence of atrial fibrillation in Spain. METHODS: A cross-sectional study was conducted in the general Spanish population older than 40 years. Two-stage random sampling was used, in which first-stage units were primary care physicians randomly selected in every Spanish province and second-stage units were 20 randomly selected persons drawn from each participating physician's assigned population. The reported prevalence was standardized for the age and sex distribution of the Spanish population. The electrocardiogram recordings were read centrally. RESULTS: Overall, 8343 individuals were evaluated. The mean age was 59.2 years (95% confidence interval, 58.6-59.8 years), and 52.4% of the participants were female. The overall age-adjusted prevalence of atrial fibrillation was 4.4% (95% confidence interval, 3.8-5.1). Prevalence was similar in both sexes, men 4.4% (3.6-5.2) and women 4.5% (3.6-5.3), rising with increasing age older than 60 years. In patients older than 80 years, the prevalence was 17.7% (14.1-21.3). In 10% of patients an unknown atrial fibrillation was diagnosed. CONCLUSIONS: The prevalence of atrial fibrillation in the general Spanish population older than 40 years is high, at 4.4%. The prevalence is similar in both sexes and rises steeply above 60 years of age. It is estimated that there are over 1 million patients with atrial fibrillation in the Spanish population, of whom over 90,000 are undiagnosed.
INTRODUCTION AND OBJECTIVES:Atrial fibrillation is associated with substantial morbidity and mortality and both its incidence and prevalence are high. Nevertheless, comprehensive data on this condition in Spain are lacking. The aim of this study was to estimate the prevalence of atrial fibrillation in Spain. METHODS: A cross-sectional study was conducted in the general Spanish population older than 40 years. Two-stage random sampling was used, in which first-stage units were primary care physicians randomly selected in every Spanish province and second-stage units were 20 randomly selected persons drawn from each participating physician's assigned population. The reported prevalence was standardized for the age and sex distribution of the Spanish population. The electrocardiogram recordings were read centrally. RESULTS: Overall, 8343 individuals were evaluated. The mean age was 59.2 years (95% confidence interval, 58.6-59.8 years), and 52.4% of the participants were female. The overall age-adjusted prevalence of atrial fibrillation was 4.4% (95% confidence interval, 3.8-5.1). Prevalence was similar in both sexes, men 4.4% (3.6-5.2) and women 4.5% (3.6-5.3), rising with increasing age older than 60 years. In patients older than 80 years, the prevalence was 17.7% (14.1-21.3). In 10% of patients an unknown atrial fibrillation was diagnosed. CONCLUSIONS: The prevalence of atrial fibrillation in the general Spanish population older than 40 years is high, at 4.4%. The prevalence is similar in both sexes and rises steeply above 60 years of age. It is estimated that there are over 1 million patients with atrial fibrillation in the Spanish population, of whom over 90,000 are undiagnosed.
Authors: Marc Casajuana; Maria Giner-Soriano; Albert Roso-Llorach; Cristina Vedia; Concepció Violan; Rosa Morros Journal: Eur J Health Econ Date: 2018-02-20
Authors: P Carrasco-Garrido; V Hernández-Barrera; J Esteban-Hernández; I Jiménez-Trujillo; A Álvaro-Meca; A López de Andrés; J de Miguel Diez; J M Rodríguez Barrios; J A Muñoz Robles; R Jiménez-García Journal: BMJ Open Date: 2017-01-10 Impact factor: 2.692
Authors: Jonas Hald; Peter Bo Poulsen; Ina Qvist; Lisbeth Holm; Dorte Wedell-Wedellsborg; Lars Dybro; Lars Frost Journal: PLoS One Date: 2017-11-13 Impact factor: 3.240
Authors: Nicole Lowres; Jake Olivier; Tze-Fan Chao; Shih-Ann Chen; Yi Chen; Axel Diederichsen; David A Fitzmaurice; Juan Jose Gomez-Doblas; Joseph Harbison; Jeff S Healey; F D Richard Hobbs; Femke Kaasenbrood; William Keen; Vivian W Lee; Jes S Lindholt; Gregory Y H Lip; Georges H Mairesse; Jonathan Mant; Julie W Martin; Enrique Martín-Rioboó; David D McManus; Javier Muñiz; Thomas Münzel; Juliet Nakamya; Lis Neubeck; Jessica J Orchard; Luis Ángel Pérula de Torres; Marco Proietti; F Russell Quinn; Andrea K Roalfe; Roopinder K Sandhu; Renate B Schnabel; Breda Smyth; Apurv Soni; Robert Tieleman; Jiguang Wang; Philipp S Wild; Bryan P Yan; Ben Freedman Journal: PLoS Med Date: 2019-09-25 Impact factor: 11.069
Authors: Gustavo Zapata-Wainberg; Sonia Quintas; Álvaro Ximénez-Carrillo Rico; Jaime Masjuán Vallejo; Pere Cardona; Mar Castellanos Rodrigo; Lorena Benavente Fernández; Andrés García Pastor; José Egido; José Maciñeiras; Joaquín Serena; María Del Mar Freijo Guerrero; Francisco Moniche; José Vivancos Journal: Interv Neurol Date: 2018-04-04
Authors: E Tamayo Aguirre; A Galo-Anza; O Dorronsoro-Barandiaran; E Uranga-Saez Del Burgo; A Ostiza Irigoyen; A Garcia-Carro; I Lopez-Fernandez; N Colera; P Saez-Garbayo; I Tamayo-Uria Journal: BMC Cardiovasc Disord Date: 2016-09-13 Impact factor: 2.298
Authors: Ana Cristina Cabellos-García; Antonio Martínez-Sabater; Enrique Castro-Sánchez; Mari Kangasniemi; Raul Juárez-Vela; Vicente Gea-Caballero Journal: BMC Public Health Date: 2018-10-04 Impact factor: 3.295